JUL 07, 2020 6:23 AM PDT

Throat Swabs Prevent COVID False Negatives

WRITTEN BY: Tara Fernandez

False-negative results are particularly problematic in containing the spread of COVID-19 — infected individuals can unwittingly transmit the virus while being completely asymptomatic. Why do false negatives happen? A recent study by Johns Hopkins researchers reported that timing may be an important factor; testing too early increased the chances of a false negative test. Here, the authors estimated that those tested for SARS-CoV-2 four days after infection were 67 percent more likely to test negative, even if they had the virus.

A study published in the Journal of Dental Research proposes a new method for reducing the occurrences of false negatives, simply by changing the sample source.

There are two main COVID-19 diagnostic tests, one that detects the presence of the SARS-CoV-2 virus, and the other that picks up antibodies, the body’s immune response to infection. The viral tests involve swabbing the inside of the nose and analyzing the sample for trace amounts of viral genetic material.

A study led by Jingzhi Ma at Wuhan’s Huazhong University of Science and Technology discovered that some patients who had negative results from their nasal swabs did in fact test positive from swabs of their oropharyngeal secretions (OS). Sampling the oropharynx, an anatomical region that includes the soft palate, throat, tonsils, and back of the tongue may be a more effective approach for catching COVID-19 positive cases sooner.

The authors found that oropharyngeal swabs significantly outperformed nasal swabs in terms of both sensitivity and accuracy: throat swabs missed only 14 percent of positive cases, as opposed to almost 60 percent that were missed by the nasal swabs.

With over 11 million confirmed cases of COVID-19 worldwide, the race to find point-of-care diagnostics, effective therapeutics, and long-term protection through vaccines continue. In the lead up to these becoming widely available, early detection of cases coupled with physical distancing provide the best chances of coronavirus transmission among the community.

Ma and colleagues support making OS sampling the new gold standard for COVID-19 diagnostics. "The NPS test has a risk of sending home more patients who still have the infection while the OS test will make such errors in fewer patients. Although OS sampling improves the accuracy of SARS-CoV-2 nucleic acid testing, it must be emphasized that this conclusion is based on a very small sample size," said Ma.

 

 

Sources: Science Daily, Technology Networks, Journal of Dental Research.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JAN 07, 2021
Cardiology
Climbing Some Stairs is a Good Way to Check Heart Health
JAN 07, 2021
Climbing Some Stairs is a Good Way to Check Heart Health
If you can climb four flights in under a minute, your heart is probably in good shape, according to new work presented a ...
JAN 26, 2021
Clinical & Molecular DX
Prostate Cancer Screening: No More False Positives
JAN 26, 2021
Prostate Cancer Screening: No More False Positives
A new diagnostic test powered by artificial intelligence has been found to detect prostate cancer markers in urine sampl ...
MAR 25, 2021
Clinical & Molecular DX
Police Speeding Radar Technology Used to Catch Antibiotic-Resistant Bacteria
MAR 25, 2021
Police Speeding Radar Technology Used to Catch Antibiotic-Resistant Bacteria
Doppler radars are used by cops to catch speeding drivers, in spacecraft navigation, and for forecasting the weather. No ...
APR 13, 2021
Clinical & Molecular DX
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
APR 13, 2021
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
German researchers have developed an innovative method for continuously tracking and monitoring biomarkers and drugs cir ...
APR 29, 2021
Clinical & Molecular DX
Can We Diagnose Disease Based on How "Sticky" Cells Are?
APR 29, 2021
Can We Diagnose Disease Based on How "Sticky" Cells Are?
How “sticky” cells are, or their viscosity, holds a wealth of information about their health and functionali ...
MAY 10, 2021
Clinical & Molecular DX
Noninvasive Device Warns When Wounds Are Bleeding
MAY 10, 2021
Noninvasive Device Warns When Wounds Are Bleeding
Patients with kidney failure have to undergo hemodialysis—a process where a dialysis machine takes the place of ki ...
Loading Comments...